Corgenix Medical Corporation Reaches Milestone in Development of New Test Format
DENVER--(BUSINESS WIRE)--Corgenix Medical Corporation (OTCQB: CONX.PK) has successfully completed the feasibility stage for a new, high-speed automated test format for its AspirinWorks® Test. Developed in collaboration with Randox Laboratories, the new format will make it faster and easier to perform the AspirinWorks Test at clinical laboratories and hospitals around the world.